American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography
- PMID: 18992671
- DOI: 10.1016/j.echo.2008.09.009
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography
Abstract
ACCREDITATION STATEMENT: The American Society of Echocardiography (ASE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASE designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.trade mark Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Registry of Diagnostic Medical Sonographers and Cardiovascular Credentialing International recognize the ASE's certificates and have agreed to honor the credit hours toward their registry requirements for sonographers. The ASE is committed to resolving all conflict-of-interest issues, and its mandate is to retain only those speakers with financial interests that can be reconciled with the goals and educational integrity of the educational program. Disclosure of faculty and commercial support sponsor relationships, if any, have been indicated.
Target audience: This activity is designed for all cardiovascular physicians, cardiac sonographers, and nurses with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, sonographers, and other medical professionals having a specific interest in contrast echocardiography may be included.
Objectives: Upon completing this activity, participants will be able to: 1. Demonstrate an increased knowledge of the applications for contrast echocardiography and their impact on cardiac diagnosis. 2. Differentiate the available ultrasound contrast agents and ultrasound equipment imaging features to optimize their use. 3. Recognize the indications, benefits, and safety of ultrasound contrast agents, acknowledging the recent labeling changes by the US Food and Drug Administration (FDA) regarding contrast agent use and safety information. 4. Identify specific patient populations that represent potential candidates for the use of contrast agents, to enable cost-effective clinical diagnosis. 5. Incorporate effective teamwork strategies for the implementation of contrast agents in the echocardiography laboratory and establish guidelines for contrast use. 6. Use contrast enhancement for endocardial border delineation and left ventricular opacification in rest and stress echocardiography and unique patient care environments in which echocardiographic image acquisition is frequently challenging, including intensive care units (ICUs) and emergency departments. 7. Effectively use contrast echocardiography for the diagnosis of intracardiac and extracardiac abnormalities, including the identification of complications of acute myocardial infarction. 8. Assess the common pitfalls in contrast imaging and use stepwise, guideline-based contrast equipment setup and contrast agent administration techniques to optimize image acquisition.
Similar articles
-
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051. Int J MS Care. 2016. PMID: 27999526 Free PMC article.
-
Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.Ital Heart J. 2004 Apr;5(4):309-34. Ital Heart J. 2004. PMID: 15185894 Review.
-
Contrast echocardiography: current and future applications.J Am Soc Echocardiogr. 2000 Apr;13(4):331-42. doi: 10.1067/mje.2000.105462. J Am Soc Echocardiogr. 2000. PMID: 10756254 Review.
-
Clinical application and laboratory protocols for performing contrast echocardiography.Indian Heart J. 2013 May-Jun;65(3):337-46. doi: 10.1016/j.ihj.2013.04.002. Epub 2013 Apr 6. Indian Heart J. 2013. PMID: 23809394 Free PMC article.
-
Home study course: spring 2009.J Low Genit Tract Dis. 2009 Apr;13(2):120-4. doi: 10.1097/LGT.0b013e3181a129e9. J Low Genit Tract Dis. 2009. PMID: 19387136 Review.
Cited by
-
Effect of combined Zhuang medicine treatment on tricuspid annular displacement and heart rate variability in rheumatoid arthritis patients.Am J Transl Res. 2024 Jul 15;16(7):2953-2962. doi: 10.62347/NHTG3720. eCollection 2024. Am J Transl Res. 2024. PMID: 39114726 Free PMC article.
-
The intersection of heart failure and cancer in women: a review.Front Cardiovasc Med. 2024 Feb 28;11:1276141. doi: 10.3389/fcvm.2024.1276141. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38481958 Free PMC article. Review.
-
The value of ultrasound enhancing agents in the echocardiographic acquisition of pulmonary artery systolic pressure: An invasive to non-invasive correlation study.Int J Cardiovasc Imaging. 2024 Apr;40(4):821-830. doi: 10.1007/s10554-024-03051-9. Epub 2024 Jan 18. Int J Cardiovasc Imaging. 2024. PMID: 38236363
-
Uncommon manifestation of multiple myeloma: A case report of intracardiac plasmacytoma presenting with severe heart failure and bilateral pleural effusion.Int J Surg Case Rep. 2024 Jan;114:109187. doi: 10.1016/j.ijscr.2023.109187. Epub 2023 Dec 29. Int J Surg Case Rep. 2024. PMID: 38160518 Free PMC article.
-
Contrast echocardiography: a practical guideline from the British Society of Echocardiography.Echo Res Pract. 2023 Nov 15;10(1):23. doi: 10.1186/s44156-023-00034-9. Echo Res Pract. 2023. PMID: 37964335 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
